Ann: Ethics Approval & Expedited Pathway for Phase 3 OA Trial, page-160

Being an MSB holder and despite @Sector filthing up the MSB board with his incessant downramping, I really don't understand the dumb rivalry going on here. We are both in the same game and success from any serious player in this field is a win for the other serious players as it denotes acceptance at the most important levels. If MSB succeeds in becoming the first stem cell co to gain FDA acceptance and commercialisation then that can only be good for CYP. And beyond all this, we have all invested to make money right (altruistic ideas aside) so lets hold tight if we believe and have done our research and let our individual SP's and collective success do the talking.